S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
NASDAQ:ONEM

1Life Healthcare (ONEM) Stock Forecast, Price & News

$8.11
-0.41 (-4.81%)
(As of 05/18/2022 04:00 PM ET)
Add
Compare
Today's Range
$8.01
$8.63
50-Day Range
$6.24
$11.97
52-Week Range
$5.94
$38.16
Volume
1.62 million shs
Average Volume
2.65 million shs
Market Capitalization
$1.57 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.87
30 days | 90 days | 365 days | Advanced Chart
Receive ONEM News and Ratings via Email

Sign-up to receive the latest news and ratings for 1Life Healthcare and its competitors with MarketBeat's FREE daily newsletter.

1Life Healthcare logo

About 1Life Healthcare

1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ONEM
Fax
N/A
Employees
3,090
Year Founded
N/A

Sales & Book Value

Annual Sales
$623.32 million
Book Value
$9.06 per share

Profitability

Net Income
$-254.64 million
Pretax Margin
-42.18%

Debt

Price-To-Earnings

Miscellaneous

Free Float
175,419,000
Market Cap
$1.57 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
5/04/2022
Today
5/18/2022
Next Earnings (Estimated)
8/03/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.46 out of 5 stars

Medical Sector

161st out of 1,426 stocks

Offices & Clinics Of Medical Doctors Industry

3rd out of 13 stocks

Analyst Opinion: 4.4Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -













1Life Healthcare (NASDAQ:ONEM) Frequently Asked Questions

Is 1Life Healthcare a buy right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for 1Life Healthcare in the last twelve months. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" 1Life Healthcare stock.
View analyst ratings for 1Life Healthcare
or view top-rated stocks.

When is 1Life Healthcare's next earnings date?

1Life Healthcare is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for 1Life Healthcare
.

How were 1Life Healthcare's earnings last quarter?

1Life Healthcare, Inc. (NASDAQ:ONEM) announced its quarterly earnings results on Wednesday, May, 4th. The company reported ($0.47) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.49) by $0.02. The business earned $254.10 million during the quarter, compared to the consensus estimate of $246.57 million. 1Life Healthcare had a negative net margin of 40.50% and a negative trailing twelve-month return on equity of 21.62%. The company's quarterly revenue was up 109.4% on a year-over-year basis. During the same period in the previous year, the business posted ($0.29) earnings per share.
View 1Life Healthcare's earnings history
.

What guidance has 1Life Healthcare issued on next quarter's earnings?

1Life Healthcare issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.05 billion-$1.09 billion, compared to the consensus revenue estimate of $1.07 billion.

What price target have analysts set for ONEM?

14 analysts have issued twelve-month price targets for 1Life Healthcare's shares. Their forecasts range from $10.00 to $32.00. On average, they expect 1Life Healthcare's share price to reach $19.33 in the next year. This suggests a possible upside of 138.4% from the stock's current price.
View analysts' price targets for 1Life Healthcare
or view top-rated stocks among Wall Street analysts.

Who are 1Life Healthcare's key executives?
1Life Healthcare's management team includes the following people:
  • Mr. Amir Dan Rubin MBA, Chairman, CEO & Pres (Age 52, Pay $1.79M)
  • Mr. Bjorn B. Thaler, Chief Financial Officer (Age 45, Pay $997.78k)
  • Mr. Stuart Parmenter, Chief Technology Officer
  • Mr. Ken Goff, VP of Investor Relations
  • Ms. Lisa A. Mango, Gen. Counsel & Corp. Sec. (Age 54, Pay $676.04k) (LinkedIn Profile)
  • Mr. Christopher Hollander, Chief Marketing Officer
  • Ms. Christine Morehead, Chief People Officer
  • Dr. Andrew S. Diamond M.D., Ph.D., Chief Medical Officer (Age 51, Pay $757.12k)
  • Mr. Rajneesh Behal M.D., MPH, Chief Quality Officer
  • Ms. Jenni Vargas, Chief Strategy Officer
What is Amir Dan Rubin's approval rating as 1Life Healthcare's CEO?

98 employees have rated 1Life Healthcare CEO Amir Dan Rubin on Glassdoor.com. Amir Dan Rubin has an approval rating of 71% among 1Life Healthcare's employees.

What other stocks do shareholders of 1Life Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 1Life Healthcare investors own include Teladoc Health (TDOC), Advanced Micro Devices (AMD), Fastly (FSLY), Etsy (ETSY), Livongo Health (LVGO), NVIDIA (NVDA), Boeing (BA), Alibaba Group (BABA), Walt Disney (DIS) and DocuSign (DOCU).

When did 1Life Healthcare IPO?

(ONEM) raised $262 million in an initial public offering (IPO) on Friday, January 31st 2020. The company issued 17,500,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Allen & Company LLC, Citigroup, Piper Jaffray, Wells Fargo Securities, William Blair, Baird and SunTrust Robinson Humphrey were co-managers.

What is 1Life Healthcare's stock symbol?

1Life Healthcare trades on the NASDAQ under the ticker symbol "ONEM."

Who are 1Life Healthcare's major shareholders?

1Life Healthcare's stock is owned by many different retail and institutional investors. Top institutional investors include Tiger Global Management LLC (9.11%), Vanguard Group Inc. (7.45%), Addition Three General Partner L.P. (4.69%), Sheares Healthcare Group Pte. Ltd. (4.30%), ARK Investment Management LLC (3.13%) and Bank of New York Mellon Corp (2.75%). Company insiders that own 1Life Healthcare stock include Amir Dan Rubin, Andrew S Diamond, Bjorn B Thaler, David P Kennedy, Holmes Kalen, Kimber D Lockhart, Kimber D Lockhart, Lisa A Mango and Lisa A Mango.
View institutional ownership trends for 1Life Healthcare
.

Which institutional investors are selling 1Life Healthcare stock?

ONEM stock was sold by a variety of institutional investors in the last quarter, including Group One Trading L.P., Bank of New York Mellon Corp, Zurcher Kantonalbank Zurich Cantonalbank , Gilder Gagnon Howe & Co. LLC, Rhenman & Partners Asset Management AB, PEAK6 Investments LLC, Jane Street Group LLC, and Exchange Traded Concepts LLC.
View insider buying and selling activity for 1Life Healthcare
or view top insider-selling stocks.

Which institutional investors are buying 1Life Healthcare stock?

ONEM stock was acquired by a variety of institutional investors in the last quarter, including Tiger Global Management LLC, Addition Three General Partner L.P., ARK Investment Management LLC, William Marsh Rice University, Vanguard Group Inc., State of New Jersey Common Pension Fund D, Integral Health Asset Management LLC, and State Street Corp.
View insider buying and selling activity for 1Life Healthcare
or or view top insider-buying stocks.

How do I buy shares of 1Life Healthcare?

Shares of ONEM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is 1Life Healthcare's stock price today?

One share of ONEM stock can currently be purchased for approximately $8.11.

How much money does 1Life Healthcare make?

1Life Healthcare has a market capitalization of $1.57 billion and generates $623.32 million in revenue each year. The company earns $-254.64 million in net income (profit) each year or ($1.78) on an earnings per share basis.

How many employees does 1Life Healthcare have?

1Life Healthcare employs 3,090 workers across the globe.

What is 1Life Healthcare's official website?

The official website for 1Life Healthcare is www.onemedical.com.

How can I contact 1Life Healthcare?

1Life Healthcare's mailing address is One Embarcadero Center Suite 1900, San Francisco CA, 94111. The company can be reached via phone at 415-814-0927 or via email at [email protected].

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.